country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Ampicillin in portal and peripheral blood and bile after oral administration of ampicillin and pivampicillin

Eur J Clin Pharmacol. 1974;7(2):133-5. doi: 10.1007/BF00561327.

B Lund , C Mogensen , J Molholm-Hansen , J Kampmann , K Siersbaek-Nielsen

PMID: 4850504 DOI: 10.1007/BF00561327

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-B0522

Ampicillin

99.92%, Bacterial Inhibitor

target: Bacterial; Antibiotic

Research Areas: Infection
HY-B0522A

Ampicillin sodium

98.0%, Bacterial Inhibitor

target: Bacterial; Antibiotic

Research Areas: Neurological Disease; Infection
HY-B0522R

Ampicillin (Standard)

99.89%, Bacterial Inhibitor

target: Reference Standards; Bacterial; Antibiotic

Research Areas: Infection
HY-B0522B

Ampicillin trihydrate

99.92%, Bacterial Inhibitor

target: Bacterial; Antibiotic

Research Areas: Infection
HY-B0522S

Ampicillin-d₅

99.4%, Stable Isotope

target: Bacterial; Antibiotic

Research Areas: Infection
HY-B0522AR

Ampicillin sodium (Standard)

Bacterial Inhibitor

target: Reference Standards; Bacterial; Antibiotic

Research Areas: Infection
HY-B0522BR

Ampicillin trihydrate (Standard)

Bacterial Inhibitor

target: Reference Standards; Bacterial; Antibiotic

Research Areas: Infection